Capgras Syndrome Subbarayan Dhivagar1, Jasmine Farhana2
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Prevalence of Capgras Syndrome in Alzheimer's Patients
Dement Neuropsychol 2019 December;13(4):463-468 Original Article http://dx.doi.org/10.1590/1980-57642018dn13-040014 Prevalence of Capgras syndrome in Alzheimer’s patients A systematic review and meta-analysis Gabriela Caparica Muniz Pereira1 , Gustavo Carvalho de Oliveira2 ABSTRACT. The association between Capgras syndrome and Alzheimer’s disease has been reported in several studies, but its prevalence varies considerably in the literature, making it difficult to measure and manage this condition. Objective: This study aims to estimate the prevalence of Capgras syndrome in patients with Alzheimer’s disease through a systematic review, and to review etiological and pathophysiological aspects related to the syndrome. Methods: A systematic review was conducted using the Medline, ISI, Cochrane, Scielo, Lilacs, and Embase databases. Two independent researchers carried out study selection, data extraction, and qualitative analysis by strictly following the same methodology. Disagreements were resolved by consensus. The meta-analysis was performed using the random effect model. Results: 40 studies were identified, 8 of which were included in the present review. Overall, a total of 1,977 patients with Alzheimer’s disease were analyzed, and the prevalence of Capgras syndrome in this group was 6% (CI: 95% I² 54% 4.0-8.0). Conclusion: The study found a significant prevalence of Capgras syndrome in patients with Alzheimer’s disease. These findings point to the need for more studies on the topic to improve the management of these patients. Key words: Capgras syndrome, Alzheimer’s disease, dementia, delusion, meta-analysis. PREVALÊNCIA DA SÍNDROME DE CAPGRAS EM PACIENTES COM DOENÇA DE ALZHEIMER: UMA REVISÃO SISTEMÁTICA E METANÁLISE RESUMO. -
Paranoid – Suspicious; Argumentative; Paranoid; Continually on The
Disorder Gathering 34, 36, 49 Answer Keys A N S W E R K E Y, Disorder Gathering 34 1. Avital Agoraphobia – 2. Ewelina Alcoholism – 3. Martyna Anorexia – 4. Clarissa Bipolar Personality Disorder –. 5. Lysette Bulimia – 6. Kev, Annabelle Co-Dependant Relationship – 7. Archer Cognitive Distortions / all-of-nothing thinking (Splitting) – 8. Josephine Cognitive Distortions / Mental Filter – 9. Mendel Cognitive Distortions / Disqualifying the Positive – 10. Melvira Cognitive Disorder / Labeling and Mislabeling – 11. Liat Cognitive Disorder / Personalization – 12. Noa Cognitive Disorder / Narcissistic Rage – 13. Regev Delusional Disorder – 14. Connor Dependant Relationship – 15. Moira Dissociative Amnesia / Psychogenic Amnesia – (*Jason Bourne character) 16. Eylam Dissociative Fugue / Psychogenic Fugue – 17. Amit Dissociative Identity Disorder / Multiple Personality Disorder – 18. Liam Echolalia – 19. Dax Factitous Disorder – 20. Lorna Neurotic Fear of the Future – 21. Ciaran Ganser Syndrome – 22. Jean-Pierre Korsakoff’s Syndrome – 23. Ivor Neurotic Paranoia – 24. Tucker Persecutory Delusions / Querulant Delusions – 25. Lewis Post-Traumatic Stress Disorder – 26. Abdul Proprioception – 27. Alisa Repressed Memories – 28. Kirk Schizophrenia – 29. Trevor Self-Victimization – 30. Jerome Shame-based Personality – 31. Aimee Stockholm Syndrome – 32. Delphine Taijin kyofusho (Japanese culture-specific syndrome) – 33. Lyndon Tourette’s Syndrome – 34. Adar Social phobias – A N S W E R K E Y, Disorder Gathering 36 Adjustment Disorder – BERKELEY Apotemnophilia -
“Cat-Gras” Delusion: a Unique Misidentification Syndrome and a Novel Explanation
Neurocase The Neural Basis of Cognition ISSN: 1355-4794 (Print) 1465-3656 (Online) Journal homepage: http://www.tandfonline.com/loi/nncs20 “Cat-gras” delusion: a unique misidentification syndrome and a novel explanation R. Ryan Darby & David Caplan To cite this article: R. Ryan Darby & David Caplan (2016) “Cat-gras” delusion: a unique misidentification syndrome and a novel explanation, Neurocase, 22:2, 251-256, DOI: 10.1080/13554794.2015.1136335 To link to this article: https://doi.org/10.1080/13554794.2015.1136335 Published online: 14 Jan 2016. Submit your article to this journal Article views: 1195 View related articles View Crossmark data Citing articles: 4 View citing articles Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=nncs20 Download by: [Vanderbilt University Library] Date: 06 December 2017, At: 06:39 NEUROCASE, 2016 VOL. 22, NO. 2, 251–256 http://dx.doi.org/10.1080/13554794.2015.1136335 “Cat-gras” delusion: a unique misidentification syndrome and a novel explanation R. Ryan Darbya,b,c and David Caplana,c aDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA; bDepartment of Neurology, Brigham and Women’s Hospital, Boston, MA, USA; cHarvard Medical School, Boston, MA, USA ABSRACT ARTICLE HISTORY Capgras syndrome is a distressing delusion found in a variety of neurological and psychiatric diseases Received 23 June 2015 where a patient believes that a family member, friend, or loved one has been replaced by an imposter. Accepted 20 December 2015 Patients recognize the physical resemblance of a familiar acquaintance but feel that the identity of that KEYWORDS person is no longer the same. -
Presentation and Care of a Family with Huntington Disease in a Resource
Charles et al. Journal of Clinical Movement Disorders (2017) 4:4 DOI 10.1186/s40734-017-0050-6 RESEARCHARTICLE Open Access Presentation and care of a family with Huntington disease in a resource-limited community Jarmal Charles1†, Lindyann Lessey1†, Jennifer Rooney1†, Ingmar Prokop1, Katherine Yearwood1, Hazel Da Breo1, Patrick Rooney1, Ruth H. Walker2,3 and Andrew K. Sobering1* Abstract Background: In high-income countries patients with Huntington disease (HD) typically present to healthcare providers after developing involuntary movements, or for pre-symptomatic genetic testing if at familial risk. A positive family history is a major guide when considering the decision to perform genetic testing for HD, both in affected and unaffected patients. Management of HD is focused upon control of symptoms, whether motor, cognitive, or psychiatric. There is no clear evidence to date of any disease-modifying agents. Referral of families and caregivers for psychological and social support, whether to HD-focused centers, or through virtual communities, is viewed as an important consequence of diagnosis. The experience of healthcare for such progressive neurodegenerative diseases in low- and middle-income nations is in stark contrast with the standard of care in high-income countries. Methods: An extended family with many members affected with an autosomal dominantly inherited movement disorder came to medical attention when one family member presented following a fall. Apart from one family member who was taking a benzodiazepine for involuntary movements, no other affected family members had sought medical attention. Members of this family live on several resource-limited Caribbean islands. Care of the chronically ill is often the responsibility of the family, and access to specialty care is difficult to obtain, or is unavailable. -
EASA Psychiatric Medication Guide Draft 5 12/8/17 1
EASA Psychiatric Medication Guide Draft 5 12/8/17 Early Assessment & Support Alliance Center for Excellence (EASA4E) Medication Guide Authors: Suki K Conrad, M. Saul Farris, Daniel Nicoli, Richard Ly, Kali Hobson, Rachel Morenz, Elizabeth Schmick, Jessica Myers, Keenan Smart, Anushka Shenoy, and Craigan Usher Illustrator: Shane Nelson Introduction For many Early Assessment Support Alliance (EASA) participants, intervention with psychiatric medications is an essential component of recovery. EASA functions as a transdisciplinary team and thus we hope to familiarize all providers in the program with the following: the rationale for medication treatment decisions, general treatment targets, as well as the side-effect profiles for six commonly utilized medication classes (see table 1.) Table 1: Commonly utilized medication classes. Medication Class Description Also known as “neuroleptics,” this group can be broken down into first- generation antipsychotics (FGAs) and second-generation antipsychotics Antipsychotic (SGAs). These medications mainly work by blocking dopamine receptors— essentially “turning down the volume” on many psychotic symptoms. Includes serotonin reuptake inhibitors (SRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), atypical agents, and tricyclic antidepressants Antidepressant (TCAs). These medications mainly work by increasing neurotransmitter levels and changing the sensitivity of receptors to neurotransmitters, alleviating depression and reducing anxiety. Includes medications such as lithium and anticonvulsants -
Brain Connectivity of Lesions Causing Delusional Misidentifications
doi:10.1093/brain/aww288 BRAIN 2017: 140; 497–507 | 497 Finding the imposter: brain connectivity of lesions causing delusional misidentifications R. Ryan Darby,1,2,3,* Simon Laganiere,1,* Alvaro Pascual-Leone,1 Sashank Prasad4 and Michael D. Fox1,2,5 *These authors contributed equally to this work. See McKay and Furl (doi:10.1093/aww323) for a scientific commentary on this article. Focal brain injury can sometimes lead to bizarre symptoms, such as the delusion that a family member has been replaced by an imposter (Capgras syndrome). How a single brain lesion could cause such a complex disorder is unclear, leading many to speculate that concurrent delirium, psychiatric disease, dementia, or a second lesion is required. Here we instead propose that Capgras and other delusional misidentification syndromes arise from single lesions at unique locations within the human brain connectome. This hypothesis is motivated by evidence that symptoms emerge from sites functionally connected to a lesion location, not just the lesion location itself. First, 17 cases of lesion-induced delusional misidentifications were identified and lesion locations were mapped to a common brain atlas. Second, lesion network mapping was used to identify brain regions functionally connected to the lesion locations. Third, regions involved in familiarity perception and belief evaluation, two processes thought to be abnormal in delu- sional misidentifications, were identified using meta-analyses of previous functional magnetic resonance imaging studies. We found that all 17 lesion locations were functionally connected to the left retrosplenial cortex, the region most activated in functional magnetic resonance imaging studies of familiarity. Similarly, 16 of 17 lesion locations were functionally connected to the right frontal cortex, the region most activated in functional magnetic resonance imaging studies of expectation violation, a component of belief evaluation. -
Parkinson's Disease: What You and Your Family Should Know
Parkinson’s Disease: What You and Your Family Should Know Edited by Gale Kittle, RN, MPH Parkinson’s Disease: What You and Your Family Should Know Table of Contents Chapter 1: Parkinson’s Disease: A Basic Understanding .....................................3 Chapter 2: Medical and Surgical Treatment Options ..........................................11 Chapter 3: Staying Well with Parkinson’s Disease ...............................................16 Chapter 4: Taking Charge of Your Health Care .....................................................22 Chapter 5: Accepting and Adapting to PD ..............................................................27 Chapter 6: Special Concerns of Persons with Young Onset Parkinson’s Disease ........................................................31 Glossary ........................................................................................................................36 About the National Parkinson Foundation ................................................................................38 Acknowledgements ....................................................................................................................... 40 Parkinson’s Disease: What You and Your Family Should Know Chapter 1 Parkinson’s Disease’s: A Basic Understanding Parkinson’s disease (PD) is a complex disorder of the brain. Because it is a disease that affects the brain, it is classified as a neurological disorder – neurological means “related to the nerves” – and the doctors who specialize in diseases that affect the -
Prevalence and Classification of Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study Part 1
ORIGINAL CONTRIBUTION Prevalence and Classification of Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study Part 1 Oscar L. Lopez, MD; William J. Jagust; Steven T. DeKosky, MD; James T. Becker, PhD; Annette Fitzpatrick, PhD; Corinne Dulberg, PhD; John Breitner, MD; Constantine Lyketsos, MD; Beverly Jones, MD; Claudia Kawas, MD; Michelle Carlson, PhD; Lewis H. Kuller, MD Objective: To examine the prevalence of mild cogni- was classified as either MCI amnestic-type or MCI mul- tive impairment (MCI) and its diagnostic classification tiple cognitive deficits–type. in the Cardiovascular Health Study (CHS) Cognition Study. Results: The overall prevalence of MCI was 19% (465 of 2470 participants); prevalence increased with age from Design: The CHS Cognition Study is an ancillary study 19% in participants younger than 75 years to 29% in those of the CHS that was conducted to determine the pres- older than 85 years. The overall prevalence of MCI at the ence of MCI and dementia in the CHS cohort. Pittsburgh center was 22% (130 of 599 participants); prevalence of the MCI amnesic-type was 6% and of the Setting: Multicenter population study. MCI multiple cognitive deficits–type was 16%. Patients: We examined 3608 participants in the CHS Conclusions: Twenty-two percent of the participants who had undergone detailed neurological, neuropsycho- aged 75 years or older had MCI. Mild cognitive impair- logical, neuroradiological, and psychiatric testing to iden- ment is a heterogenous syndrome, where the MCI am- tify dementia and MCI. nestic-type is less frequent than the MCI multiple cog- nitive deficits–type. Most of the participants with MCI Main Outcome Measures: The prevalence of MCI was had comorbid conditions that may affect their cognitive determined for the whole cohort, and specific subtypes functions. -
Cotard's Syndrome
MIND & BRAIN, THE JOURNAL OF PSYCHIATRY REVIEW ARTICLE Cotard’s Syndrome Hans Debruyne1,2,3, Michael Portzky1, Kathelijne Peremans1 and Kurt Audenaert1 Affiliations: 1Department of Psychiatry, University Hospital Ghent, Ghent, Belgium; 2PC Dr. Guislain, Psychiatric Hospital, Ghent, Belgium and 3Department of Psychiatry, Zorgsaam/RGC, Terneuzen, The Netherlands ABSTRACT Cotard’s syndrome is characterized by nihilistic delusions focused on the individual’s body including loss of body parts, being dead, or not existing at all. The syndrome as such is neither mentioned in DSM-IV-TR nor in ICD-10. There is growing unanimity that Cotard’s syndrome with its typical nihilistic delusions externalizes an underlying disorder. Despite the fact that Cotard’s syndrome is not a diagnostic entity in our current classification systems, recognition of the syndrome and a specific approach toward the patient is mandatory. This paper overviews the historical aspects, clinical characteristics, classification, epidemiology, and etiological issues and includes recent views on pathogenesis and neuroimaging. A short overview of treatment options will be discussed. Keywords: Cotard’s syndrome, nihilistic delusion, misidentification syndrome, review Correspondence: Hans Debruyne, P.C. Dr. Guislain Psychiatric Hospital Ghent, Fr. Ferrerlaan 88A, 9000 Ghent, Belgium. Tel: 32 9 216 3311; Fax: 32 9 2163312; e-mail: [email protected] INTRODUCTION: HISTORICAL ASPECTS AND of the syndrome. They described a nongeneralized de´lire de CLASSIFICATION negation, associated with paralysis, alcoholic psychosis, dementia, and the ‘‘real’’ Cotard’s syndrome, only found in Cotard’s syndrome is named after Jules Cotard (1840Á1889), anxious melancholia and chronic hypochondria.6 Later, in a French neurologist who described this condition for the 1968, Saavedra proposed a classification into three types: first time in 1880, in a case report of a 43-year-old woman. -
On the Edge of Capgras' Syndrome
JOURNAL OF PSYCHOPATHOLOGY Online First Case report 2021;Mar 20. doi: 10.36148/2284-0249-386 On the edge of Capgras’ syndrome Andrea Turano1, Cecilia Caravaggi2, Giuseppe Ducci2, Silvia Bernardini2, Pier Luca Bandinelli2 1 Department of Pyschiatry, Sapienza University of Rome, Sant’Andrea Hospital, Rome, Italy; 2 Department of Mental Health ASL Roma 1, Rome, Italy SUMMARY Capgras’ syndrome, the delusional belief in the existence of doubles of others or of one- self, belongs to the delusional misidentification syndromes (DMSs), a group of syndromes characterized by delusional misidentification of oneself and/or of other people. These syn- dromes are not codified as diagnoses per se on the DSM-5 or on the ICD-11, and are usually seen as specific presentations of broader psychiatric disorders. Capgras’ syndrome has been shown on both psychiatric and non-psychiatric disorders, thus not being a manageable tool in helping clinicians to define a diagnosis. Presenting what we believe is a special case of Capgras’ syndrome, we aim to propose a characterization of such syndrome very specific of schizophrenic – and thus psychiatric – conditions, which may turn especially useful in clinical pictures where no other psychiatric or medical symptoms are found and can help defining a diagnosis. Key words: Capgras’ syndrome, delusional misidentification syndromes, differential diagnosis Non c’è uomo che a forza di portare una maschera, non finisca per assimilare a questa anche il suo vero volto. Received: April 30, 2020 Accepted: December 10, 2020 (Nathaniel Hawthorne; La lettera scarlatta) Correspondence Pier Luca Bandinelli Introduction Department of Psychiatry, SPDC San Filippo In classic psychopathology there was a tendency toward giving names Neri, via G. -
Functional Neurological Disorder: a Practical Guide to an Elusive Dx
Roselyn W. Clemente Fuentes, MD, FAAFP; Functional neurological Merima Bucaj, DO, FAAFP; Sundonia J. W. Wonnum, PhD, LCSW disorder: A practical guide Eglin Family Medicine Residency, Eglin Air Force Base, FL (Dr. Clemente to an elusive Dx Fuentes); Abrazo Health Network Family Medicine Residency, Phoenix, AZ The complexity of this disorder poses a clinical challenge (Dr. Bucaj); Defense Health Headquarters, Falls Church, like few others. VA (Dr. Wonnum) roselynjan.w.fuentes. [email protected] CASE u The authors reported no PRACTICE John D,* a 25-year-old patient with an otherwise unremarkable potential conflict of interest RECOMMENDATIONS relevant to this article. medical history, describes 2 months of daily headache, lower- ❯ Avoid using stigmatizing extremity weakness, and unsteady gait that began fairly sud- The opinions and assertions terminology (eg, adding contained herein are the private denly during his first deployment in the US Army. He explains views of the authors and are not the prefix “pseudo” or the to be construed as official or as that these symptoms affected his ability to perform his duties adjective “hysterical”) to reflecting the views of the US Air and necessitated an early return stateside for evaluation and Force Medical Department or the characterize a suspected US Air Force at large. functional neurological treatment. disorder (FND) or a Mr. D denies precipitating trauma or unusual environmen- doi: 10.12788/jfp.0155 medically unexplained tal exposures. He reports that, stateside now, symptoms con- disorder. C tinue to affect his ability to work and attend to personal and ❯ Refrain from ordering family responsibilities. functional magnetic Asked about stressors, Mr. -
Functional Neurological Disorder
Functional Neurological Disorder (FND) Learning guide Written by: Phuong Nhan, Registered Nurse Vincent Cheah, Registered Nurse Reviewed by: Dr Alexander Lehn, Neurologist Dr Megan Broughton, Neuropsychologist Dr Rian Dob, Neuropsychologist Dharsha Navaratnam, Physiotherapist Our Mission In the spirit of the Sisters of Mercy, the Mater Hospital offers compassionate service to the sick and needy, promotes an holistic approach to healthcare in response to changing community needs and fosters high standards in health-related education and research. Following the example of Christ the healer, we commit ourselves to offering these services to all without discrimination. Our Values Mercy: The spirit of responding to one another Dignity: The spirit of humanity, respecting the worth of each person Care: The spirit of compassion Commitment: The spirit of integrity Quality: The spirit of professionalism 2 Contents Functional Neurological Disorder learning guide 4 Aim ........................................................................................................ 4 Guide outline .......................................................................................... 4 Introduction to FND 5 What is FND? .......................................................................................... 5 A brief history of FND .............................................................................. 5 Glossary of key terminologies 6 Who is at risk? 7 Symptoms of FND 8 Functional motor disorders ....................................................................